Target intelligence / Profile preview

Herpesvirus DNA-directed DNA polymerase (Pol)

Target
Pol
Molecular classification
Enzyme, DNA polymerase, Family B DNA polymerase
01

Overview

Herpesvirus DNA-directed DNA polymerase is a fundamental enzyme required for the replication of the double-stranded DNA genomes of viruses within the Herpesviridae family, including Herpes Simplex Virus (HSV), Varicella-Zoster Virus (VZV), and Cytomegalovirus (CMV) [3, 5]. This enzyme belongs to the Family B DNA polymerases and typically operates as a complex comprising a catalytic subunit and a processivity factor that enhances the enzyme's ability to synthesize long DNA strands without dissociating [3, 5]. The catalytic subunit exhibits both 5'-3' polymerase activity for DNA synthesis and 3'-5' exonuclease activity for proofreading, which is vital for maintaining viral genetic stability [3, 7]. As an essential component of the viral lytic cycle, it serves as the primary target for the majority of approved anti-herpetic medications [1, 3]. Drugs such as acyclovir and ganciclovir act as prodrugs that, once activated by viral kinases, competitively inhibit the polymerase and induce premature chain termination of the nascent viral DNA [1, 2]. Other inhibitors, like foscarnet, bind directly to the pyrophosphate-binding site of the enzyme to block its activity [1, 6]. Despite the success of these therapies, the development of resistance through mutations in the polymerase gene is a major concern, especially during long-term treatment in immunocompromised individuals [3, 4].

Other names
Viral DNA polymeraseDNA-directed DNA polymerase catalytic subunitUL30UL54BALF5Herpesvirus DNA polymerase
02

Mechanism of action

The primary mechanism of action for drugs targeting this enzyme involves the use of nucleoside or nucleotide analogues that act as competitive inhibitors of the viral DNA polymerase and/or as DNA chain terminators after being incorporated into the growing viral DNA strand [1, 2, 3]. Additionally, pyrophosphate analogues like foscarnet directly inhibit the enzyme by binding to its pyrophosphate-binding site, preventing the release of pyrophosphate from deoxynucleoside triphosphates and halting DNA synthesis [1, 6].

03

Biological functions

DNA replicationDNA synthesis3'-5' exonuclease activityProofreadingRibonuclease H activity
04

Disease associations

InfectionHerpes simplexVaricellaHerpes zosterCytomegalovirus infectionInfectious mononucleosisEncephalitisKeratitis
05

Safety considerations

Emergence of drug-resistant viral strainsNephrotoxicityMyelosuppressionNeurotoxicity
06

Interacting drugs

Acyclovir

8 more in the full profile.

07

Biomarkers

Viral DNA load (PCR-based detection)Mutations in the UL30 or UL54 genesViral antigen detection

Beyond the preview

Go deeper on Herpesvirus DNA-directed DNA polymerase (Pol).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Herpesvirus DNA-directed DNA polymerase (Pol).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call